![1]()
News
PACT-HF: Transitional care derives no overall benefit
January 9, 2020
PHILADELPHIA – A trial of a postdischarge transitional care model found no improvement in outcomes overall, but showed that women responded more favorably than men.
![1]()
News
New hypertension performance measures boost 130/80 mm Hg target
January 6, 2020
PHILADELPHIA – Hypertension performance and quality measures from the AHA and ACC provide a guide for implementing the 2017 hypertension guideline.
![1]()
News
Farxiga granted Priority Review for treatment of adults with HFrEF
January 6, 2020
The Food and Drug Administration is reviewing dapagliflozin for reducing the risk of cardiovascular death or worsening of heart failure in adults with heart failure with reduced ejection fraction based on DAPA-HF.
![1]()
News
ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding
December 16, 2019
LOS ANGELES – Use of novel oral anticoagulants may be preferred over vitamin K antagonists in patients with diabetes and AFib.
![1]()
News
New ASH guideline: VTE prophylaxis after major surgery
December 12, 2019
ORLANDO – The chair of VTE guidelines panel presented highlights of the latest guidelines in a special session at the annual meeting of the American Society of Hematology.
![1]()
News
Cardiac arrhythmia heightens mortality risk during epilepsy hospitalizations
December 11, 2019
BALTIMORE – A secondary diagnosis of apnea is not independently associated with increased odds of death, however.
![1]()
News
Genetic test stratified AFib patients with low CHA2DS2-VASc scores
December 9, 2019
A 32-locus genetic test classified AFib patients with low CHA2DS2-VASc scores into high– and low–stroke-risk subgroups.
![1]()
News
New heart failure trial data presage guideline revisions
December 9, 2019
PHILADELPHIA – Recent trial findings for sacubitril/valsartan and dapagliflozin in heart failure patients provide a blueprint for guideline changes.
![1]()
News
Aspirin plus a DOAC may do more harm than good in some
December 8, 2019
Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication increased bleeding risks in a large cohort.
![1]()
News
DAPA-HF: Dapagliflozin benefits regardless of age, HF severity
November 25, 2019
PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.
